Aarti Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has submitted to the stock exchanges a Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. The certificate was issued by MUFG Intime India Private Limited (formerly Link Intime), the company's Registrar and Transfer Agent. It confirms that all share certificates received from depository participants for dematerialization during the quarter were properly verified, listed, and the depositories' names were entered in the register of members within the required timelines. The filing was signed by Rushikesh Deole, Company Secretary and Compliance Officer.
This is a routine quarterly compliance filing with no material impact on shareholders or the stock price. It simply confirms the company's RTA has properly processed dematerialization requests during the October–December 2025 quarter.